TeraWulf (WULF) 10-K 5 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Feb. 23, 2014	Jun. 30, 2013
Document and Entity Information	'	'	'
Entity Registrant Name	'IKONICS CORP	'	'
Entity Central Index Key	'0001083301	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$14,554,296
Entity Common Stock, Shares Outstanding	'	2,012,170	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:	'	'
Cash and cash equivalents (Note 7)	$1,704,300	$967,943
Short-term investments	1,464,878	1,442,939
Trade receivables, less allowance of $62,000 in 2013 and $43,000 in 2012 (Notes 5, 7, and 8)	2,050,853	2,060,312
Inventories (Note 8)	2,554,942	2,678,864
Prepaid expenses and other assets	103,687	124,983
Income tax receivable	16,400	'
Deferred income taxes (Note 2)	150,000	142,000
Total current assets	8,045,060	7,417,041
PROPERTY, PLANT, AND EQUIPMENT, at cost:	'	'
Land and buildings	6,123,890	6,063,965
Machinery and equipment	3,781,282	3,219,598
Office equipment	722,567	700,062
Vehicles	237,194	237,488
Gross property, plant, and equipment, at cost	10,864,933	10,221,113
Less accumulated depreciation	5,230,837	4,759,235
Net property, plant, and equipment, at cost	5,634,096	5,461,878
INTANGIBLE ASSETS, less accumulated amortization of $535,421 in 2013 and $482,107 in 2012 (Note 3)	322,647	305,357
Total assets	14,001,803	13,184,276
CURRENT LIABILITIES:	'	'
Accounts payable	532,294	593,922
Accrued compensation	274,936	265,822
Other accrued liabilities	67,755	81,635
Income taxes payable	'	82,152
Total current liabilities	874,985	1,023,531
DEFERRED INCOME TAXES (Note 2)	527,000	366,000
Total liabilities	1,401,985	1,389,531
STOCKHOLDERS' EQUITY:	'	'
Preferred stock, par value $.10 per share; authorized 250,000 shares: issued none	'	'
Common stock, par value $.10 per share; authorized 4,750,000 shares: issued and outstanding 2,012,170 shares in 2013 and 1,998,475 shares in 2012 (Note 6)	201,217	199,848
Additional paid-in capital	2,592,038	2,470,507
Retained earnings	9,806,563	9,124,390
Total stockholders' equity	12,599,818	11,794,745
Total liabilities and stockholders' equity	$14,001,803	$13,184,276

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
CONDENSED BALANCE SHEETS	'	'
Trade receivables, allowance (in dollars)	$62,000	$43,000
INTANGIBLE ASSETS, accumulated amortization (in dollars)	$535,421	$482,107
Preferred stock, par value (in dollars per share)	$0.10	$0.10
Preferred stock, shares authorized	250,000	250,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized	4,750,000	4,750,000
Common stock, shares issued	2,012,170	1,998,475
Common stock, shares outstanding	2,012,170	1,998,475

STATEMENTS_OF_INCOME

STATEMENTS OF INCOME (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CONDENSED STATEMENTS OF INCOME	'	'
NET SALES	$17,491,408	$17,312,407
COST OF GOODS SOLD	10,553,553	10,367,563
GROSS PROFIT	6,937,855	6,944,844
SELLING, GENERAL AND ADMINSTRATIVE EXPENSES	5,368,400	5,282,187
RESEARCH AND DEVELOPMENT EXPENSES	649,325	629,776
OPERATING EXPENSES	6,017,725	5,911,963
INCOME FROM OPERATIONS	920,130	1,032,881
INTEREST INCOME	7,043	12,050
INCOME BEFORE INCOME TAXES	927,173	1,044,931
FEDERAL AND STATE INCOME TAXES (Note 2)	245,000	351,000
NET INCOME	$682,173	$693,931
EARNINGS PER COMMON SHARE:	'	'
Basic (in dollars per share)	$0.34	$0.35
Diluted (in dollars per share)	$0.34	$0.35
WEIGHTED AVERAGE COMMON SHARES:	'	'
Basic (in shares)	2,006,843	1,988,066
Diluted (in shares)	2,010,659	1,990,847

STATEMENTS_OF_STOCKHOLDERS_EQU

STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings
BALANCE at Dec. 31, 2011	$12,990,543	$198,459	$2,363,150	$10,428,934
BALANCE (in shares) at Dec. 31, 2011	'	1,984,587	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'
Net income	693,931	'	'	693,931
Exercise of stock options	89,028	1,389	87,639	'
Exercise of stock options (in shares)	'	13,888	'	'
Cash dividend paid	-1,998,475	'	'	-1,998,475
Tax benefit resulting from stock option exercises	1,900	'	1,900	'
Stock based compensation and related tax benefit	17,818	'	17,818	'
BALANCE at Dec. 31, 2012	11,794,745	199,848	2,470,507	9,124,390
BALANCE (in shares) at Dec. 31, 2012	1,998,475	1,998,475	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'
Net income	682,173	'	'	682,173
Exercise of stock options	89,398	1,369	88,029	'
Exercise of stock options (in shares)	'	13,695	'	'
Tax benefit resulting from stock option exercises	19,595	'	19,595	'
Stock based compensation and related tax benefit	13,907	'	13,907	'
BALANCE at Dec. 31, 2013	$12,599,818	$201,217	$2,592,038	$9,806,563
BALANCE (in shares) at Dec. 31, 2013	2,012,170	2,012,170	'	'

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net income	$682,173	$693,931
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	568,791	489,206
Amortization	53,314	54,653
Stock based compensation	13,907	17,818
Net gain on sale of vehicles and equipment exchange	-13,979	-7,163
Loss on intangible asset abandonment	'	23,122
Deferred income taxes	153,000	30,000
Changes in working capital components:	'	'
Trade receivables	9,459	120,635
Inventories	123,922	-444,030
Prepaid expenses and other assets	21,296	-42,060
Income tax refund receivable	-16,400	59,322
Accounts payable	-61,628	44,390
Accrued liabilities	-4,766	58,074
Income taxes payable	-62,557	84,052
Net cash provided by operating activities	1,466,532	1,181,950
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Purchases of property and equipment	-762,537	-566,519
Proceeds from sale of equipment and vehicles	35,507	59,500
Purchases of intangibles	-70,604	-56,770
Purchases of short-term investments	-1,814,878	-1,857,990
Proceeds from sale of short-term investments	1,792,939	2,250,054
Net cash used in investing activities	-819,573	-171,725
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Cash dividend paid	'	-1,998,475
Proceeds from exercise of stock options	89,398	89,028
Net cash provided by (used in) financing activities	89,398	-1,909,447
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	736,357	-899,222
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	967,943	1,867,165
CASH AND CASH EQUIVALENTS AT END OF YEAR	1,704,300	967,943
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	'	'
Cash paid for income taxes, net of refunds received of $13,026 and $61,650, respectively	$171,139	$177,626

STATEMENTS_OF_CASH_FLOWS_Paren

STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CONDENSED STATEMENTS OF CASH FLOWS	'	'
Income taxes, refunds received	$13,026	$61,650

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	1.                            SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Description of Business and Foreign Export Sales - IKONICS Corporation (the Company) develops and manufactures high-quality photochemical imaging systems for sale primarily to a wide range of printers and decorators of surfaces.  Customers’ applications are primarily screen printing and abrasive etching.  The Company’s principal markets are throughout the United States.  In addition, the Company sells to Europe, Latin America, Asia, and other parts of the world.  The Company extends credit to its customers, all on an unsecured basis, on terms that it establishes for individual customers.
	Foreign export sales approximated 32.3% of net sales in 2013 and 31.9% of net sales in 2012.  The Company’s trade receivables at December 31, 2013 and 2012 due from foreign customers were 32.5% and 34.4% of total trade receivables, respectively.  The foreign export receivables are composed primarily of open credit arrangements with terms ranging from 30 to 90 days.  No single customer or foreign country represented greater than 10% of net sales in 2013 or in 2012.
	The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.  Subsequent events have been evaluated through March 5, 2014, the date the financial statements were issued.
	A summary of the Company’s significant accounting policies follows:
	Cash Equivalents - The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.  Cash equivalents consist of money market funds in which the carrying value approximates market value because of the short maturity of these instruments.  The money market fund utilized by IKONICS invests in United States dollar denominated securities that present minimal credit risk and consist of investments in debt securities issued or guaranteed by the United States government or by United States government agencies or instrumentalities and repurchase agreements fully collateralized by the United States Treasury and United States government securities.
	Short-Term Investments - Short-term investments consist of fully insured certificates of deposit with original maturities ranging from six to twelve months as of December 31, 2013 and 2012, respectively.
	Trade Receivables — Trade receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on an on-going basis.  Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.  Trade receivables are written off when deemed uncollectible.  Recoveries of trade receivables previously written off are recorded when received.  Accounts are considered past due if payment is not received according to agreed-upon terms.
	A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any given country.  At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency. These balances are adjusted to each quarter or year end spot rate in accordance with FASB ASC 830, Foreign Currency Matters.  Foreign currency transactions and translation adjustments did not have a significant effect on the Balance Sheet or the Statements of Income, Stockholders’ Equity and Cash Flows for 2013 and 2012.
	Inventories - Inventories are stated at the lower of cost or market using the last-in, first-out (LIFO) method.  If the first-in, first-out (FIFO) cost method had been used, inventories would have been approximately $1,248,000 and $1,246,000 higher than reported at December 31, 2013 and 2012, respectively.  The major components of inventories are as follows:
		2013			2012
	Raw materials	$	1,952,398		$	2,072,540
	Work-in-progress	389,501			373,512
	Finished goods	1,461,264			1,478,444
	Reduction to LIFO cost	(1,248,221		)	(1,245,632		)
	Total inventories	$	2,554,942		$	2,678,864
	Depreciation - Depreciation of property, plant and equipment is computed using the straight-line method over the following estimated useful lives:
		Years
	Buildings	15-40
	Machinery and equipment	10-May
	Office equipment	10-Mar
	Vehicles	3
	Intangible Assets — Intangible assets consist of patents, licenses and covenants not to compete arising from business combinations.  Intangible assets are amortized on a straight-line basis over their estimated useful lives or agreement terms.  Intangible assets with indefinite lives are assessed for impairment whenever events or circumstances indicate the carrying value may not be fully recoverable by comparing the carrying value of the intangibles to their future undiscounted cash flows.  To the extent the undiscounted cash flows are less than the carrying value, analysis is performed based on several criteria, including, but not limited to, revenue trends, discounted operating cash flows and other operating factors to determine the impairment amount.
	As of December 31, 2013, the remaining estimated weighted average useful lives of intangible assets are as follows:
		Years
	Patents	14.3
	Licenses	3.4
	Non-compete agreements	1.5
	Fair Value of Financial Instruments — The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, trade receivables, accounts payable, and accrued liabilities approximate fair value due to the short maturities of these instruments.
	Revenue Recognition - The Company recognizes revenue on sales of products when title passes which can occur at the time of shipment or when the goods arrive at the customer location depending on the agreement with the customer.  The Company sells its products to both distributors and end-users.  Sales to distributors and end-users are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser.  In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the criteria outlined within SAB 104 and FASB ASC 605 Revenue Recognition:
	(a) persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s sales invoices, as generally there is no other formal agreement underlying the sale transactions)
	(b) delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms.  Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete)
	(c) a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions)
	(d) a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a substantial history of customer defaults or non-payment)
	Sales are reported on a net basis by deducting credits, estimated normal returns and discounts.  The Company’s return policy does not vary by geography.  The customer has no rotation or price protection rights and the Company is not under a warranty obligation.  Freight billed to customers is included in sales.  Shipping costs are included in cost of goods sold.
	Self-Funded Medical Insurance - Beginning in January 2012, the Company moved from a fully insured to a self-funded medical insurance plan. The Company contracted with an administrative service company or a “third party administrator” to supervise and administer the program and act as the Company’s fiduciary and representative. The Company has reduced its risk under this self-funded plan by purchasing both specific and aggregate stop-loss insurance coverage for individual claims and total annual claims in excess of prescribed limits. The Company records estimates for claim liabilities based on information provided by the third-party administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company regularly monitors its estimated insurance-related liabilities.  Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred. The total liability for self-funded medical insurance was $55,000 as of December 31, 2013 and $54,000 as of December 31, 2012.  The liability related to self-funded medical insurance is included within other accrued liabilities in the balance sheet.
	Deferred Taxes - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.  The Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement.  The guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods.
	Earnings Per Common Share (EPS) - Basic EPS is calculated using net income divided by the weighted average of common shares outstanding.  Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares, when dilutive, that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued.
	Shares used in the calculation of diluted EPS are summarized below:
		2013		2012
	Weighted average common shares outstanding	2,006,843		1,988,066
	Dilutive effect of stock options	3,816		2,781
	Weighted average common and common equivalent shares outstanding	2,010,659		1,990,847
	There were no anti-dilutive options at December 31, 2013 and 2012.
	Employee Stock Plan - The Company accounts for employee stock options under the provision of ASC 718 Compensation — Stock Compensation.
	Use of Estimates - The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include the allowance for doubtful trade receivables, the reserve for inventory obsolescence, self-funded health insurance, and the valuation allowance for deferred tax assets.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2013
INCOME TAXES	'
INCOME TAXES	'
	2.                           INCOME TAXES
	Income tax expense for the years ended December 31, 2013 and 2012 consists of the following:
		2013			2012
	Current:
	Federal	$	91,000		$	319,000
	State	1,000			2,000
		92,000			321,000
	Deferred	153,000			30,000
		$	245,000		$	351,000
	The expected provision for income taxes, computed by applying the U.S. federal income tax rate of 34% in 2013 and 35% in 2012 to income before taxes, is reconciled to income tax expense as follows:
		2013			2012
	Expected provision for federal income taxes	$	315,000		$	365,700
	State income taxes, net of federal benefit	16,000			(400		)
	Domestic manufacturers deduction	(20,000		)	(31,800		)
	Non-deductible meals, entertainment, and life insurance	13,000			20,800
	Prior year adjustments	(32,000		)	—
	Research and development credit	(45,000		)	—
	Other	(2,000		)	(3,300		)
		$	245,000		$	351,000
	Net deferred tax liabilities consist of the following as of December 31, 2013 and 2012:
		2013			2012
	Deferred tax assets:
	Accrued vacation	$	23,000		$	25,000
	Inventories reserve	105,000			101,000
	Allowance for doubtful accounts	9,000			5,000
	Allowance for sales returns	13,000			11,000
	Capital loss carryforward	309,000			323,000
	Research and development credit carryforward	17,000			—
	Less valuation allowance	(326,000		)	(323,000		)
		150,000			142,000
	Deferred tax liabilities:
	Property and equipment and other assets	(468,000		)	(324,000		)
	Intangible assets	(59,000		)	(42,000		)
	Net deferred tax liabilities	$	(377,000	)	$	(224,000	)
	The deferred tax amounts described above have been included in the accompanying balance sheet as of December 31, 2013 and 2012 as follows:
		2013			2012
	Current assets	$	150,000		$	142,000
	Noncurrent liabilities	(527,000		)	(366,000		)
		$	(377,000	)	$	(224,000	)
	At December 31, 2013 and 2012, the Company recorded a valuation allowance of $326,000 and $323,000, respectively, related to Minnesota research and development credit and U.S. Federal capital loss carryovers as the company believes it is more likely than not that the deferred tax assets will not be realized.  As of December 31, 2013, the capital loss can be carried forward one year and must be offset by a capital gain.
	It has been the Company’s policy to recognize interest and penalties related to uncertain tax positions in income tax expense.  As of December 31, 2013 and 2012, there was no liability for unrecognized tax benefits.
	The Company is subject to federal and state taxation.  The material jurisdictions that are subject to examination by tax authorities primarily include Minnesota and the United States, for tax years 2010, 2011, 2012 and 2013.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS	'
INTANGIBLE ASSETS	'
	3.                           INTANGIBLE ASSETS
	Intangible assets consist of patents, patent applications, licenses and covenants not to compete arising from business combinations.  Capitalized patent application costs are included with patents.  Intangible assets are amortized on a straight-line basis over their estimated useful lives or terms of their agreement, whichever is shorter.  The Company wrote off costs related to patent applications of $23,000 in 2012.  No other impairment adjustments to intangible assets were made during the years ended December 31, 2013 or 2012.
	Intangible assets at December 31, 2013 and 2012 consist of the following:
		December 31, 2013					December 31, 2012
		Gross Carrying		Accumulated			Gross Carrying		Accumulated
		Amount		Amortization			Amount		Amortization
	Amortized intangible assets:
	Patents	$	455,068	$	(155,970	)	$	384,464	$	(141,447	)
	Licenses	100,000		(86,459		)	100,000		(83,334		)
	Non-compete agreements	303,000		(292,992		)	303,000		(257,326		)
		$	858,068	$	(535,421	)	$	787,464	$	(482,107	)
		2013		2012
	Aggregate amortization expense:
	For the years ended December 31	$	53,314	$	54,653
	Estimated amortization expense for the years ending December 31:
	2014	$	25,000
	2015	23,000
	2016	20,000
	2017	20,000
	2018	18,000
	In connection with the license agreements, the Company has agreed to pay royalties ranging from 3% to 5% on the sales of products subject to the agreements.  The Company incurred $19,000 of expense under these agreements during 2013, and $87,000 during 2012 which have been included in selling, general and administrative expenses in the Statements of Income.

RETIREMENT_PLAN

RETIREMENT PLAN	12 Months Ended
	Dec. 31, 2013
RETIREMENT PLAN	'
RETIREMENT PLAN	'
	4.                           RETIREMENT PLAN
	The Company has established a salary deferral plan under Section 401(k) of the Internal Revenue Code.  Such deferrals accumulate on a tax-deferred basis until the employee withdraws the funds.  The Company contributes up to 5% of each eligible employee’s compensation.  Total retirement expense for the years ended December 31, 2013 and 2012 was approximately $208,000 and $204,000, respectively.

SEGMENT_INFORMATION

SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2013
SEGMENT INFORMATION	'
SEGMENT INFORMATION	'
	5.                           SEGMENT INFORMATION
	The Company’s reportable segments are strategic business units that offer different products and have varied customer bases.  There are five reportable segments:  Domestic, Export, IKONICS Imaging, Digital Texturing (DTX) and Micro-Machining.  Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada.  IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States and Canada.  Micro-Machining provides sound deadening technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers.  DTX includes products and customers related to patented and proprietary inkjet technology used for mold texturing.  Export sells primarily the same products as Domestic and the IKONICS Imaging products not related to Micro-Machining or DTX.  In previous periods, the segment designated as Other included both Micro-Machining and DTX.  Beginning in 2013, the Company began to report DTX and Micro-Machining as separate segments.  The accounting policies of the segments are the same as those described in the summary of significant accounting policies included in Note 1.
	Management evaluates the performance of each segment based on the components of divisional income, and does not allocate assets and liabilities to segments except for trade receivables.  Financial information with respect to the reportable segments follows:
	For the year ended December 31, 2013:
								IKONICS					Micro-
		Domestic			Export			Imaging		DTX			Machining			Unalloc.			Total
	Net sales	$	7,260,934		$	5,641,544		$	3,836,762	$	407,193		$	344,975		$	—		$	17,491,408
	Cost of goods sold	4,062,141			4,057,111			1,831,047		70,343			532,911			—			10,553,553
	Gross profit (loss)	3,198,793			1,584,433			2,005,715		336,850			(187,936		)	—			6,937,855
	Selling general and adminstrative*	1,307,154			578,084			977,574		474,782			446,803			1,584,003			5,368,400
	Research and development*	—			—			—		—			—			649,325			649,325
	Income (loss) from operations	$	1,891,639		$	1,006,349		$	1,028,141	$	(137,932	)	$	(634,739	)	$	(2,233,328	)	$	920,130
	For the year ended December 31, 2012:
								IKONICS					Micro-
		Domestic			Export			Imaging		DTX			Machining			Unalloc.			Total
	Net sales	$	7,118,912		$	5,523,177		$	3,708,987	$	470,205		$	491,126		$	—		$	17,312,407
	Cost of goods sold	4,036,339			4,042,689			1,705,054		118,349			465,132			—			10,367,563
	Gross profit	3,082,573			1,480,488			2,003,933		351,856			25,994			—			6,944,844
	Selling general and adminstrative*	1,226,107			607,453			1,099,812		493,631			314,803			1,540,381			5,282,187
	Research and development*	—			—			—		—			—			629,776			629,776
	Income (loss) from operations	$	1,856,466		$	873,035		$	904,121	$	(141,775	)	$	(288,809	)	$	(2,170,157	)	$	1,032,881
	* The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.
	Trade receivables by segment as of December 31, 2013 and December 31, 2012 were as follows:
		Dec 31, 2013			Dec 31, 2012
	Domestic	$	1,012,057		$	928,698
	Export	667,343			708,933
	IKONICS Imaging	339,537			272,346
	DTX	26,910			117,552
	Micro-Machining	40,222			57,122
	Unallocated	(35,216		)	(24,339		)
	Total	$	2,050,853		$	2,060,312

STOCK_OPTIONS

STOCK OPTIONS	12 Months Ended
	Dec. 31, 2013
STOCK OPTIONS	'
STOCK OPTIONS	'
	6.                           STOCK OPTIONS
	The Company has a stock incentive plan for the issuance of up to 442,750 shares of common stock.  The plan provides for granting eligible participants stock options or other stock awards, as described by the plan, at option prices ranging from 85% to 110% of fair market value at date of grant.  Options granted expire up to seven years after the date of grant.  Such options generally become exercisable over a three year period.  A total of 115,573 shares of common stock are reserved for additional grants of options under the plan at December 31, 2013.
	Under the plan, the Company charged compensation cost of $13,907 and $17,818 against income in 2013 and 2012, respectively.
	As of December 31, 2013, there was approximately $20,000 of unrecognized compensation cost related to unvested share-based compensation awards granted which is expected to be recognized over the next three years.
	Proceeds from the exercise of stock options were $89,398 for 2013 and $89,028 for 2012.
	The fair value of options granted during 2013 and 2012 were estimated using the Black-Scholes option pricing model with the following assumptions:
		2013		2012
	Dividend yield	0%		0%
	Expected volatility	43.90%		41.80%
	Expected life of option	Five Years		Five Years
	Risk-free interest rate	0.70%		0.80%
	Fair value of each option on grant date	$4.72		$2.73
	There were 4,250 options and 750 options granted during 2013 and 2012, respectively.
	FASB ASC 718, Compensation — Stock Compensation specifies that initial accruals be based on the estimated number of instruments for which the requisite service is expected to be rendered.  Therefore, the Company is required to incorporate a preexisting forfeiture rate based on the historical forfeiture experience and prospective actuarial analysis, estimated at 3%.
	A summary of the status of the Company’s stock option plan as of December 31, 2013 and changes during the year then ended is presented below:
	Options	Shares		Weighted			Weighted	Aggregate
				Average			Average	Intrinsic
				Exercise			Remaining	Value
				Price			Contractual
							Term (years)
	Outstanding at January 1, 2013	21,362		$	6.72
	Granted	4,250		12.56
	Exercised	(13,695	)	6.53
	Expired and forfeited	(500	)	12.56
	Outstanding at December 31, 2013	11,417		$	8.87		2.67	$	66,876
	Vested or expected to vest at December 31, 2013	11,417		$	8.87		2.67	$	66,876
	Exercisable at December 31, 2013	4,166		$	6.57		1.24	$	33,977
	The weighted-average grant date fair value of options granted was $4.72 and $2.73 for the years ended December 31, 2013 and 2012, respectively.  The total intrinsic value of options exercised was $95,477 for the year ended December 31, 2013 and $32,650 for the year ended December 31, 2012.
	The following table summarizes information about stock options outstanding at December 31, 2013:
		Options Outstanding						Options Exercisable
				Weighted-
		Number		Average		Weighted-		Number		Weighted-
	Range of	Outstanding at		Remaining		Average		Exercisable at		Average
	Exercise	December 31,		Contractual		Exercise		December 31,		Exercise
	Price	2013		Life (years)		Price		2013		Price
	$ 5.00 - $5.99	1,500		0.31		$	5	1,500		$	5
	$ 7.00 - $7.99	6,167		2.24		$	7.56	2,666		$	7.45
	$12.00 - $13.00	3,750		4.31		$	12.56	—		$	—
		11,417		2.67		$	8.87	4,166		$	6.57

CONCENTRATION_OF_CREDIT_RISK

CONCENTRATION OF CREDIT RISK	12 Months Ended
	Dec. 31, 2013
CONCENTRATION OF CREDIT RISK	'
CONCENTRATION OF CREDIT RISK	'
	7.                           CONCENTRATION OF CREDIT RISK
	The Company maintains its cash balances primarily in two financial institutions.  As of December 31, 2013, the balance at each of the institutions exceeded the Federal Deposit Insurance Corporation coverage.
	Trade receivables are financial instruments that also expose the Company to concentration of credit risk.  The large number of customers comprising the Company’s customer base and their dispersion across different geographic areas limits such exposure. In addition, the Company routinely assesses the financial strength of its customers and maintains an allowance for doubtful accounts that management believes will adequately provide for credit losses.

LINE_OF_CREDIT

LINE OF CREDIT	12 Months Ended
	Dec. 31, 2013
LINE OF CREDIT	'
LINE OF CREDIT	'
	8.                           LINE OF CREDIT
	The Company has a $1,250,000 bank line of credit that provides for working capital financing.  This line of credit is subject to renewal on May 31, 2015, is collateralized by trade receivables and inventories, and bears interest at 2.5 percentage points over 30-day LIBOR.  There were no outstanding borrowings under this line of credit at December 31, 2013 and 2012.  There are no financial covenants related to the line of credit.

NONMONETARY_TRANSACTION

NON-MONETARY TRANSACTION	12 Months Ended
	Dec. 31, 2013
NON-MONETARY TRANSACTION	'
NON-MONETARY TRANSACTION	'
	9.                           NON-MONETARY TRANSACTION
	During 2012, the Company entered into a like-kind exchange with a customer where the Company and the Company’s customer exchanged digital texturing printers.  In addition to the Company receiving a printer from the customer, the Company also received $35,000.  A loss of $16,000 was recognized by the Company on the exchange.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
Cash Equivalents	'
	Cash Equivalents - The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.  Cash equivalents consist of money market funds in which the carrying value approximates market value because of the short maturity of these instruments.  The money market fund utilized by IKONICS invests in United States dollar denominated securities that present minimal credit risk and consist of investments in debt securities issued or guaranteed by the United States government or by United States government agencies or instrumentalities and repurchase agreements fully collateralized by the United States Treasury and United States government securities.
Short-Term Investments	'
	Short-Term Investments - Short-term investments consist of fully insured certificates of deposit with original maturities ranging from six to twelve months as of December 31, 2013 and 2012, respectively.
Trade Receivables	'
	Trade Receivables — Trade receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on an on-going basis.  Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.  Trade receivables are written off when deemed uncollectible.  Recoveries of trade receivables previously written off are recorded when received.  Accounts are considered past due if payment is not received according to agreed-upon terms.
	A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any given country.  At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency. These balances are adjusted to each quarter or year end spot rate in accordance with FASB ASC 830, Foreign Currency Matters.  Foreign currency transactions and translation adjustments did not have a significant effect on the Balance Sheet or the Statements of Income, Stockholders’ Equity and Cash Flows for 2013 and 2012.
Inventories	'
	Inventories - Inventories are stated at the lower of cost or market using the last-in, first-out (LIFO) method.  If the first-in, first-out (FIFO) cost method had been used, inventories would have been approximately $1,248,000 and $1,246,000 higher than reported at December 31, 2013 and 2012, respectively.  The major components of inventories are as follows:
		2013			2012
	Raw materials	$	1,952,398		$	2,072,540
	Work-in-progress	389,501			373,512
	Finished goods	1,461,264			1,478,444
	Reduction to LIFO cost	(1,248,221		)	(1,245,632		)
	Total inventories	$	2,554,942		$	2,678,864
Depreciation	'
	Depreciation - Depreciation of property, plant and equipment is computed using the straight-line method over the following estimated useful lives:
		Years
	Buildings	15-40
	Machinery and equipment	10-May
	Office equipment	10-Mar
	Vehicles	3
Intangible Assets	'
	Intangible Assets — Intangible assets consist of patents, licenses and covenants not to compete arising from business combinations.  Intangible assets are amortized on a straight-line basis over their estimated useful lives or agreement terms.  Intangible assets with indefinite lives are assessed for impairment whenever events or circumstances indicate the carrying value may not be fully recoverable by comparing the carrying value of the intangibles to their future undiscounted cash flows.  To the extent the undiscounted cash flows are less than the carrying value, analysis is performed based on several criteria, including, but not limited to, revenue trends, discounted operating cash flows and other operating factors to determine the impairment amount.
	As of December 31, 2013, the remaining estimated weighted average useful lives of intangible assets are as follows:
		Years
	Patents	14.3
	Licenses	3.4
	Non-compete agreements	1.5
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments — The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, trade receivables, accounts payable, and accrued liabilities approximate fair value due to the short maturities of these instruments.
Revenue Recognition	'
	Revenue Recognition - The Company recognizes revenue on sales of products when title passes which can occur at the time of shipment or when the goods arrive at the customer location depending on the agreement with the customer.  The Company sells its products to both distributors and end-users.  Sales to distributors and end-users are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser.  In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the criteria outlined within SAB 104 and FASB ASC 605 Revenue Recognition:
	(a) persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s sales invoices, as generally there is no other formal agreement underlying the sale transactions)
	(b) delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms.  Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete)
	(c) a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions)
	(d) a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a substantial history of customer defaults or non-payment)
	Sales are reported on a net basis by deducting credits, estimated normal returns and discounts.  The Company’s return policy does not vary by geography.  The customer has no rotation or price protection rights and the Company is not under a warranty obligation.  Freight billed to customers is included in sales.  Shipping costs are included in cost of goods sold.
Self-Funded Medical Insurance	'
	Self-Funded Medical Insurance - Beginning in January 2012, the Company moved from a fully insured to a self-funded medical insurance plan. The Company contracted with an administrative service company or a “third party administrator” to supervise and administer the program and act as the Company’s fiduciary and representative. The Company has reduced its risk under this self-funded plan by purchasing both specific and aggregate stop-loss insurance coverage for individual claims and total annual claims in excess of prescribed limits. The Company records estimates for claim liabilities based on information provided by the third-party administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company regularly monitors its estimated insurance-related liabilities.  Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred. The total liability for self-funded medical insurance was $55,000 as of December 31, 2013 and $54,000 as of December 31, 2012.  The liability related to self-funded medical insurance is included within other accrued liabilities in the balance sheet.
Deferred Taxes	'
	Deferred Taxes - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.  The Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement.  The guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods.
Earnings Per Common Share (EPS)	'
	Earnings Per Common Share (EPS) - Basic EPS is calculated using net income divided by the weighted average of common shares outstanding.  Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares, when dilutive, that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued.
	Shares used in the calculation of diluted EPS are summarized below:
		2013		2012
	Weighted average common shares outstanding	2,006,843		1,988,066
	Dilutive effect of stock options	3,816		2,781
	Weighted average common and common equivalent shares outstanding	2,010,659		1,990,847
	There were no anti-dilutive options at December 31, 2013 and 2012.
Employee Stock Plan	'
	Employee Stock Plan - The Company accounts for employee stock options under the provision of ASC 718 Compensation — Stock Compensation.
Use of Estimates	'
	Use of Estimates - The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include the allowance for doubtful trade receivables, the reserve for inventory obsolescence, self-funded health insurance, and the valuation allowance for deferred tax assets.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
Schedule of major components of inventories	'
		2013			2012
	Raw materials	$	1,952,398		$	2,072,540
	Work-in-progress	389,501			373,512
	Finished goods	1,461,264			1,478,444
	Reduction to LIFO cost	(1,248,221		)	(1,245,632		)
	Total inventories	$	2,554,942		$	2,678,864
Schedule of estimated useful lives of property, plant and equipment	'
		Years
	Buildings	15-40
	Machinery and equipment	10-May
	Office equipment	10-Mar
	Vehicles	3
Schedule of remaining estimated weighted average useful lives of intangible assets	'
		Years
	Patents	14.3
	Licenses	3.4
	Non-compete agreements	1.5
Summary of shares used in the calculation of diluted EPS	'
		2013		2012
	Weighted average common shares outstanding	2,006,843		1,988,066
	Dilutive effect of stock options	3,816		2,781
	Weighted average common and common equivalent shares outstanding	2,010,659		1,990,847

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2013
INCOME TAXES	'
Schedule of components of income tax expense	'
		2013			2012
	Current:
	Federal	$	91,000		$	319,000
	State	1,000			2,000
		92,000			321,000
	Deferred	153,000			30,000
		$	245,000		$	351,000
Schedule of expected provision for income taxes, computed by applying the U.S. federal income tax rate to income before taxes, reconciled to income tax expense	'
		2013			2012
	Expected provision for federal income taxes	$	315,000		$	365,700
	State income taxes, net of federal benefit	16,000			(400		)
	Domestic manufacturers deduction	(20,000		)	(31,800		)
	Non-deductible meals, entertainment, and life insurance	13,000			20,800
	Prior year adjustments	(32,000		)	—
	Research and development credit	(45,000		)	—
	Other	(2,000		)	(3,300		)
		$	245,000		$	351,000
Schedule of components of net deferred tax liabilities	'
		2013			2012
	Deferred tax assets:
	Accrued vacation	$	23,000		$	25,000
	Inventories reserve	105,000			101,000
	Allowance for doubtful accounts	9,000			5,000
	Allowance for sales returns	13,000			11,000
	Capital loss carryforward	309,000			323,000
	Research and development credit carryforward	17,000			—
	Less valuation allowance	(326,000		)	(323,000		)
		150,000			142,000
	Deferred tax liabilities:
	Property and equipment and other assets	(468,000		)	(324,000		)
	Intangible assets	(59,000		)	(42,000		)
	Net deferred tax liabilities	$	(377,000	)	$	(224,000	)
Schedule of deferred tax amounts included in the accompanying balance sheet	'
		2013			2012
	Current assets	$	150,000		$	142,000
	Noncurrent liabilities	(527,000		)	(366,000		)
		$	(377,000	)	$	(224,000	)

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS	'
Schedule of components of intangible assets	'
		December 31, 2013					December 31, 2012
		Gross Carrying		Accumulated			Gross Carrying		Accumulated
		Amount		Amortization			Amount		Amortization
	Amortized intangible assets:
	Patents	$	455,068	$	(155,970	)	$	384,464	$	(141,447	)
	Licenses	100,000		(86,459		)	100,000		(83,334		)
	Non-compete agreements	303,000		(292,992		)	303,000		(257,326		)
		$	858,068	$	(535,421	)	$	787,464	$	(482,107	)
		2013		2012
	Aggregate amortization expense:
	For the years ended December 31	$	53,314	$	54,653
Schedule of estimated amortization expense	'
	2014	$	25,000
	2015	23,000
	2016	20,000
	2017	20,000
	2018	18,000

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2013
SEGMENT INFORMATION	'
Schedule of financial information with respect to the reportable segments	'
	For the year ended December 31, 2013:
								IKONICS					Micro-
		Domestic			Export			Imaging		DTX			Machining			Unalloc.			Total
	Net sales	$	7,260,934		$	5,641,544		$	3,836,762	$	407,193		$	344,975		$	—		$	17,491,408
	Cost of goods sold	4,062,141			4,057,111			1,831,047		70,343			532,911			—			10,553,553
	Gross profit (loss)	3,198,793			1,584,433			2,005,715		336,850			(187,936		)	—			6,937,855
	Selling general and adminstrative*	1,307,154			578,084			977,574		474,782			446,803			1,584,003			5,368,400
	Research and development*	—			—			—		—			—			649,325			649,325
	Income (loss) from operations	$	1,891,639		$	1,006,349		$	1,028,141	$	(137,932	)	$	(634,739	)	$	(2,233,328	)	$	920,130
	For the year ended December 31, 2012:
								IKONICS					Micro-
		Domestic			Export			Imaging		DTX			Machining			Unalloc.			Total
	Net sales	$	7,118,912		$	5,523,177		$	3,708,987	$	470,205		$	491,126		$	—		$	17,312,407
	Cost of goods sold	4,036,339			4,042,689			1,705,054		118,349			465,132			—			10,367,563
	Gross profit	3,082,573			1,480,488			2,003,933		351,856			25,994			—			6,944,844
	Selling general and adminstrative*	1,226,107			607,453			1,099,812		493,631			314,803			1,540,381			5,282,187
	Research and development*	—			—			—		—			—			629,776			629,776
	Income (loss) from operations	$	1,856,466		$	873,035		$	904,121	$	(141,775	)	$	(288,809	)	$	(2,170,157	)	$	1,032,881
	* The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.
Schedule of trade receivables by segment	'
		Dec 31, 2013			Dec 31, 2012
	Domestic	$	1,012,057		$	928,698
	Export	667,343			708,933
	IKONICS Imaging	339,537			272,346
	DTX	26,910			117,552
	Micro-Machining	40,222			57,122
	Unallocated	(35,216		)	(24,339		)
	Total	$	2,050,853		$	2,060,312

STOCK_OPTIONS_Tables

STOCK OPTIONS (Tables)	12 Months Ended
	Dec. 31, 2013
STOCK OPTIONS	'
Assumptions used in estimating fair value of stock options	'
		2013		2012
	Dividend yield	0%		0%
	Expected volatility	43.90%		41.80%
	Expected life of option	Five Years		Five Years
	Risk-free interest rate	0.70%		0.80%
	Fair value of each option on grant date	$4.72		$2.73
Stock option activity	'
	Options	Shares		Weighted			Weighted	Aggregate
				Average			Average	Intrinsic
				Exercise			Remaining	Value
				Price			Contractual
							Term (years)
	Outstanding at January 1, 2013	21,362		$	6.72
	Granted	4,250		12.56
	Exercised	(13,695	)	6.53
	Expired and forfeited	(500	)	12.56
	Outstanding at December 31, 2013	11,417		$	8.87		2.67	$	66,876
	Vested or expected to vest at December 31, 2013	11,417		$	8.87		2.67	$	66,876
	Exercisable at December 31, 2013	4,166		$	6.57		1.24	$	33,977
Summary of information about stock options outstanding	'
		Options Outstanding						Options Exercisable
				Weighted-
		Number		Average		Weighted-		Number		Weighted-
	Range of	Outstanding at		Remaining		Average		Exercisable at		Average
	Exercise	December 31,		Contractual		Exercise		December 31,		Exercise
	Price	2013		Life (years)		Price		2013		Price
	$ 5.00 - $5.99	1,500		0.31		$	5	1,500		$	5
	$ 7.00 - $7.99	6,167		2.24		$	7.56	2,666		$	7.45
	$12.00 - $13.00	3,750		4.31		$	12.56	—		$	—
		11,417		2.67		$	8.87	4,166		$	6.57

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (Export)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Minimum	'	'
Description of Business and Foreign Export Sales	'	'
Term under credit arrangement	'30 days	'
Maximum	'	'
Description of Business and Foreign Export Sales	'	'
Term under credit arrangement	'90 days	'
Net sales | Customer concentration	'	'
Description of Business and Foreign Export Sales	'	'
Percentage of net sales and trade receivable	32.30%	31.90%
Trade receivables | Credit concentration	'	'
Description of Business and Foreign Export Sales	'	'
Percentage of net sales and trade receivable	32.50%	34.40%

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013
			Certificates of deposit	Certificates of deposit
			Minimum	Maximum
Short-term investments	'	'	'	'
Maturity period	'	'	'6 months	'12 months
Inventories	'	'	'	'
Excess of FIFO value over LIFO value	$1,248,000	$1,246,000	'	'
Major components of inventories, net of the allowance for obsolescence	'	'	'	'
Raw materials	1,952,398	2,072,540	'	'
Work-in-progress	389,501	373,512	'	'
Finished goods	1,461,264	1,478,444	'	'
Reduction to LIFO cost	-1,248,221	-1,245,632	'	'
Total inventories	$2,554,942	$2,678,864	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)	12 Months Ended
	Dec. 31, 2013
Buildings | Minimum	'
Depreciation	'
Estimated useful lives	'15 years
Buildings | Maximum	'
Depreciation	'
Estimated useful lives	'40 years
Machinery and equipment | Minimum	'
Depreciation	'
Estimated useful lives	'5 years
Machinery and equipment | Maximum	'
Depreciation	'
Estimated useful lives	'10 years
Office equipment | Minimum	'
Depreciation	'
Estimated useful lives	'3 years
Office equipment | Maximum	'
Depreciation	'
Estimated useful lives	'10 years
Vehicles	'
Depreciation	'
Estimated useful lives	'3 years

SUMMARY_OF_SIGNIFICANT_ACCOUNT6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4)	12 Months Ended
	Dec. 31, 2013
Patents	'
INTANGIBLE ASSETS	'
Remaining estimated weighted average useful lives	'14 years 3 months 18 days
Licenses	'
INTANGIBLE ASSETS	'
Remaining estimated weighted average useful lives	'3 years 4 months 24 days
Non-compete agreements	'
INTANGIBLE ASSETS	'
Remaining estimated weighted average useful lives	'1 year 6 months

SUMMARY_OF_SIGNIFICANT_ACCOUNT7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 5) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Self-Funded Medical Insurance	'	'
Total liability for self-funded medical insurance	$55,000	$54,000
Earnings Per Common Share (EPS)	'	'
Weighted average common shares outstanding	2,006,843	1,988,066
Dilutive effect of stock options	3,816	2,781
Weighted average common and common equivalent shares outstanding	2,010,659	1,990,847
Stock Options	'	'
Anti-dilutive securities	'	'
Anti-dilutive securities outstanding (in shares)	0	0

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Current:	'	'
Federal	$91,000	$319,000
State	1,000	2,000
Total current	92,000	321,000
Deferred	153,000	30,000
Income tax expense	$245,000	$351,000

INCOME_TAXES_Details_2

INCOME TAXES (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of expected provision for income taxes, computed by applying the U.S. federal income tax rate to income before taxes, to income tax expense	'	'
U.S. federal income tax rate (as a percent)	34.00%	35.00%
Expected provision for federal income taxes	$315,000	$365,700
State income taxes, net of federal benefit	16,000	-400
Domestic manufacturers deduction	-20,000	-31,800
Non-deductible meals, entertainment, and life insurance	13,000	20,800
Prior year adjustments	-32,000	'
Research and development credit	-45,000	'
Other	-2,000	-3,300
Income tax expense	245,000	351,000
Deferred tax assets:	'	'
Accrued vacation	23,000	25,000
Inventories reserve	105,000	101,000
Allowance for doubtful accounts	9,000	5,000
Allowance for sales returns	13,000	11,000
Capital loss carryforward	309,000	323,000
Research and development credit carryforward	17,000	'
Less valuation allowance	-326,000	-323,000
Total deferred tax assets	150,000	142,000
Deferred tax liabilities:	'	'
Property and equipment and other assets	-468,000	-324,000
Intangible assets	-59,000	-42,000
Net deferred tax liabilities	($377,000)	($224,000)

INCOME_TAXES_Details_3

INCOME TAXES (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred tax amounts included in balance sheet	'	'
Current assets	$150,000	$142,000
Noncurrent liabilities	-527,000	-366,000
Net deferred tax liabilities	-377,000	-224,000
Valuation allowance	326,000	323,000
Carryforward period	'1 year	'
Unrecognized tax benefits	$0	$0

INTANGIBLE_ASSETS_Details

INTANGIBLE ASSETS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
INTANGIBLE ASSETS	'	'
Patent application cost write off	'	($23,122)
Other impairment adjustments to intangible assets	0	0
Amortized intangible assets:	'	'
Gross Carrying Amount	858,068	787,464
Accumulated Amortization	-535,421	-482,107
Aggregate amortization expense:	53,314	54,653
Estimated amortization expense	'	'
2014	25,000	'
2015	23,000	'
2016	20,000	'
2017	20,000	'
2018	18,000	'
Patents	'	'
INTANGIBLE ASSETS	'	'
Patent application cost write off	'	23,000
Amortized intangible assets:	'	'
Gross Carrying Amount	455,068	384,464
Accumulated Amortization	-155,970	-141,447
Licenses	'	'
Amortized intangible assets:	'	'
Gross Carrying Amount	100,000	100,000
Accumulated Amortization	-86,459	-83,334
Estimated amortization expense	'	'
Expense under license agreement	19,000	87,000
Licenses | Minimum	'	'
Estimated amortization expense	'	'
Payment of royalties (as a percent)	3.00%	'
Licenses | Maximum	'	'
Estimated amortization expense	'	'
Payment of royalties (as a percent)	5.00%	'
Non-compete agreements	'	'
Amortized intangible assets:	'	'
Gross Carrying Amount	303,000	303,000
Accumulated Amortization	($292,992)	($257,326)

RETIREMENT_PLAN_Details

RETIREMENT PLAN (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
RETIREMENT PLAN	'	'
Maximum contribution of the entity as a percentage of eligible employee's compensation	5.00%	'
Retirement expense	$208,000	$204,000

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
	item
Segment Reporting Information	'	'
Number of reportable segments	5	'
Financial information with respect to the reportable segments	'	'
Net sales	$17,491,408	$17,312,407
Cost of goods sold	10,553,553	10,367,563
GROSS PROFIT	6,937,855	6,944,844
Selling general and administrative	5,368,400	5,282,187
Research and development	649,325	629,776
INCOME FROM OPERATIONS	920,130	1,032,881
Trade receivables by segment	'	'
Trade receivables	2,050,853	2,060,312
Unalloc.	'	'
Financial information with respect to the reportable segments	'	'
Selling general and administrative	1,584,003	1,540,381
Research and development	649,325	629,776
INCOME FROM OPERATIONS	-2,233,328	-2,170,157
Trade receivables by segment	'	'
Trade receivables	-35,216	-24,339
Domestic	'	'
Financial information with respect to the reportable segments	'	'
Net sales	7,260,934	7,118,912
Cost of goods sold	4,062,141	4,036,339
GROSS PROFIT	3,198,793	3,082,573
Selling general and administrative	1,307,154	1,226,107
INCOME FROM OPERATIONS	1,891,639	1,856,466
Trade receivables by segment	'	'
Trade receivables	1,012,057	928,698
Export	'	'
Financial information with respect to the reportable segments	'	'
Net sales	5,641,544	5,523,177
Cost of goods sold	4,057,111	4,042,689
GROSS PROFIT	1,584,433	1,480,488
Selling general and administrative	578,084	607,453
INCOME FROM OPERATIONS	1,006,349	873,035
Trade receivables by segment	'	'
Trade receivables	667,343	708,933
IKONICS Imaging	'	'
Financial information with respect to the reportable segments	'	'
Net sales	3,836,762	3,708,987
Cost of goods sold	1,831,047	1,705,054
GROSS PROFIT	2,005,715	2,003,933
Selling general and administrative	977,574	1,099,812
INCOME FROM OPERATIONS	1,028,141	904,121
Trade receivables by segment	'	'
Trade receivables	339,537	272,346
DTX	'	'
Financial information with respect to the reportable segments	'	'
Net sales	407,193	470,205
Cost of goods sold	70,343	118,349
GROSS PROFIT	336,850	351,856
Selling general and administrative	474,782	493,631
INCOME FROM OPERATIONS	-137,932	-141,775
Trade receivables by segment	'	'
Trade receivables	26,910	117,552
Micro-Machining	'	'
Financial information with respect to the reportable segments	'	'
Net sales	344,975	491,126
Cost of goods sold	532,911	465,132
GROSS PROFIT	-187,936	25,994
Selling general and administrative	446,803	314,803
INCOME FROM OPERATIONS	-634,739	-288,809
Trade receivables by segment	'	'
Trade receivables	$40,222	$57,122

STOCK_OPTIONS_Details

STOCK OPTIONS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock options	'	'
Number of shares of common stock authorized for issuance	442,750	'
Proceeds from the exercise of stock	$89,398	$89,028
Stock Options	'	'
Stock options	'	'
Expiration period of options granted	'7 years	'
Period over which options become exercisable	'3 years	'
Common stock reserved for additional grants (in shares)	115,573	'
Compensation cost recognized	13,907	17,818
Unrecognized compensation cost	20,000	'
Period during which compensation cost is expected to be recognized	'3 years	'
Proceeds from the exercise of stock	$89,398	$89,028
Assumptions used to determine fair value of stock options granted	'	'
Dividend yield (as a percent)	0.00%	0.00%
Expected volatility (as a percent)	43.90%	41.80%
Expected life of option	'5 years	'5 years
Risk-free interest rate (as a percent)	0.70%	0.80%
Fair value of each option on grant date (in dollars per share)	$4.72	$2.73
Granted (in shares)	4,250	750
Estimated forfeiture rate (as a percent)	3.00%	'
Stock Options | Minimum	'	'
Stock options	'	'
Option price range(as a percent)	85.00%	'
Stock Options | Maximum	'	'
Stock options	'	'
Option price range(as a percent)	110.00%	'

STOCK_OPTIONS_Details_2

STOCK OPTIONS (Details 2) (Stock Options, USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Options	'	'
Shares	'	'
Outstanding at beginning of period (in shares)	21,362	'
Granted (in shares)	4,250	750
Exercised (in shares)	-13,695	'
Expired and forfeited (in shares)	-500	'
Outstanding at end of period (in shares)	11,417	21,362
Vested or expected to vest at the end of the period (in shares)	11,417	'
Exercisable at end of period (in shares)	4,166	'
Weighted Average Exercise Price	'	'
Outstanding at beginning of period (in dollars per share)	$6.72	'
Granted (in dollars per share)	$12.56	'
Exercised (in dollars per share)	$6.53	'
Expired and forfeited (in dollars per share)	$12.56	'
Outstanding at end of period (in dollars per share)	$8.87	$6.72
Vested or expected to vest at the end of the period (in dollars per share)	$8.87	'
Exercisable at end of period (in dollars per share)	$6.57	'
Weighted Average Remaining Contractual Term	'	'
Outstanding at end of year	'2 years 8 months 1 day	'
Vested or expected to vest at end of period	'2 years 8 months 1 day	'
Exercisable at end of period	'1 year 2 months 26 days	'
Aggregate Intrinsic Value	'	'
Outstanding at the end of the year (in dollars)	$66,876	'
Vested or expected to vest at end of period (in dollars)	66,876	'
Exercisable at the end of the period (in dollars)	33,977	'
Weighted-average grant date fair value of options granted (in dollars per share)	$4.72	$2.73
Total intrinsic value of options exercised (in dollars)	$95,477	$32,650

STOCK_OPTIONS_Details_3

STOCK OPTIONS (Details 3) (Stock Options, USD $)	12 Months Ended
	Dec. 31, 2013
Options Outstanding	'
Number Outstanding (in shares)	11,417
Weighted-Average Remaining Contractual Life	'2 years 8 months 1 day
Weighted-Average Exercise Price (in dollars per share)	$8.87
Options Exercisable	'
Number Exercisable (in shares)	4,166
Weighted-Average Exercise Price (in dollars per share)	$6.57
$5.00 - $5.99	'
Stock options	'
Range of exercise prices, low end (in dollars per share)	$5
Range of exercise prices, high end (in dollars per share)	$5.99
Options Outstanding	'
Number Outstanding (in shares)	1,500
Weighted-Average Remaining Contractual Life	'3 months 22 days
Weighted-Average Exercise Price (in dollars per share)	$5
Options Exercisable	'
Number Exercisable (in shares)	1,500
Weighted-Average Exercise Price (in dollars per share)	$5
$7.00 - $7.99	'
Stock options	'
Range of exercise prices, low end (in dollars per share)	$7
Range of exercise prices, high end (in dollars per share)	$7.99
Options Outstanding	'
Number Outstanding (in shares)	6,167
Weighted-Average Remaining Contractual Life	'2 years 2 months 26 days
Weighted-Average Exercise Price (in dollars per share)	$7.56
Options Exercisable	'
Number Exercisable (in shares)	2,666
Weighted-Average Exercise Price (in dollars per share)	$7.45
$12.00 - $13.00	'
Stock options	'
Range of exercise prices, low end (in dollars per share)	$12
Range of exercise prices, high end (in dollars per share)	$13
Options Outstanding	'
Number Outstanding (in shares)	3,750
Weighted-Average Remaining Contractual Life	'4 years 3 months 22 days
Weighted-Average Exercise Price (in dollars per share)	$12.56

CONCENTRATION_OF_CREDIT_RISK_D

CONCENTRATION OF CREDIT RISK (Details)	12 Months Ended
	Dec. 31, 2013
	item
CONCENTRATION OF CREDIT RISK	'
Number of financial institutions in which cash balance maintained by entity in partially insured checking account	2

LINE_OF_CREDIT_Details

LINE OF CREDIT (Details) (Bank line of credit, USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Bank line of credit	'	'
Line of credit	'	'
Borrowing capacity	$1,250,000	'
Interest rate added to base rate (as a percent)	2.50%	'
Variable rate basis	'30-day LIBOR	'
Outstanding borrowings	$0	$0

NONMONETARY_TRANSACTION_Detail

NON-MONETARY TRANSACTION (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
NON-MONETARY TRANSACTION	'
Cash received from exchange of digital texturing printers	$35,000
Loss recognized on the exchange of digital texturing printers	$16,000